Hepion receives Nasdaq delisting notice for bid price below $1.00 per share

Hepion Pharmaceuticals, Inc.

Notice received June 3, 2022; stock continues trading under symbol HEPA.
Non-compliance with Nasdaq Listing Rule 5550(a)(2) for minimum $1.00 bid price.
Company has 180 calendar days, until November 30, 2022, to regain compliance.
Intends to monitor bid price and consider options to regain compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.